This study is the first to demonstrate that GMP is associated with p53 expression and the presence of germline BRCA1 mutations and it suggests that the presence of GMP is an independent risk factor for death from breast cancer comparable in magnitude to conventional prognostic factors (RR 1.9). Here, TP53 is linked to breast cancer.